Cramer Rosenthal McGlynn’s Synovus SNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-3,300
Closed -$135K 188
2017
Q1
$135K Sell
3,300
-1,236,472
-100% -$51.6M ﹤0.01% 198
2016
Q4
$50.9M Sell
1,239,772
-731,610
-37% -$26.9M 0.76% 55
2016
Q3
$64.1M Buy
1,971,382
+296,080
+18% +$9.3M 0.99% 26
2016
Q2
$48.6M Sell
1,675,302
-67,955
-4% -$2.06M 0.78% 45
2016
Q1
$50.4M Buy
1,743,257
+201,430
+13% +$5.77M 0.79% 46
2015
Q4
$49.9M Sell
1,541,827
-740,847
-32% -$23.6M 0.75% 52
2015
Q3
$67.6M Buy
2,282,674
+288,564
+14% +$8.84M 0.91% 29
2015
Q2
$61.5M Buy
1,994,110
+895,310
+81% +$25.9M 0.76% 44
2015
Q1
$30.8M Buy
+1,098,800
New +$29.8M 0.35% 114

Other funds holding SNV

Cramer Rosenthal McGlynn's SNV Position: Q2 2017 in Review

Cramer Rosenthal McGlynn sold out of Synovus (SNV) in Q2 2017, closing a stake of 3,300 shares — an estimated $135K sold.

Cramer Rosenthal McGlynn first reported a position in SNV in Q1 2015 and held it in 9 quarters. The position peaked at $67.6M in Q3 2015. 292 funds tracked by Wall St. Rank hold SNV as of Q2 2017.

  • Cramer Rosenthal McGlynn reported no remaining Synovus position as of Q2 2017 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 3,300 Synovus shares in Q2 2017, an estimated $135K.
  • Cramer Rosenthal McGlynn first reported a position in Synovus in Q1 2015 and held it in 9 quarters.
  • Cramer Rosenthal McGlynn's Synovus position peaked at $67.6M in Q3 2015.
  • 292 funds tracked by Wall St. Rank held Synovus as of Q2 2017.

Based on Cramer Rosenthal McGlynn's 13F filing for Q2 2017, filed 14 Aug 2017.